Soligenix Announces $600,000 Subaward Supporting Evaluation of Innate Defense Regulator Platform Technology as a Medical Countermeasure for Bacterial Threat Agents - PRNewswire

Soligenix Announces $600,000 Subaward Supporting Evaluation of Innate Defense Regulator Platform Technology as a Medical Countermeasure for Bacterial Threat Agents  PRNewswire

PRINCETON, N.J., May 28, 2019 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused ...



Comments

Popular posts from this blog

GROWING PROBLEM Botched penis enlargement epidemic hits Papua New Guinea as docs warn 500 have injected todgers with coconut oil - Information-Analytic Agency NEWS.am

Common Questions About Vaccines (for Parents) | Nemours KidsHealth